|
C2N Diagnostics Announces Key New Hire and $1M+ Grant from Anonymous Donor to Support Alzheimer’s Biomarkers and Diagnostics Programs |
|
March 18, 2010
ST. LOUIS, MO – C2N Diagnostics announced today that it has received a multi-year grant from an anonymous donor. The award has the potential to exceed $1M in milestone-driven funding. It significantly accelerates C2N’s efforts to develop highly informative biomarkers implicated in Alzheimer’s disease and other central nervous system (CNS) disorders. |
|
Read more...
|
|
|
C2N Diagnostics Awarded "Fast Track" SBIR by NIA/NIH |
|
December 17, 2009
ST. LOUIS, MO – C2N Diagnostics has received a Fast Track Small Business Innovation Reasearch (SBIR) Award from the National Institute On Aging (NIA), part of the National Institutes of Health (NIH). The award of nearly $1 million will fund milestone-driven research to improve the diagnosis and treatment of Alzheimer’s disease. Dr. Tim West, C2N’s Director of Laboratory Operations, will serve as the study’s principal investigator.
|
|
Read more...
|
|
|
C2N Diagnostics Announces Successful Completion of Milestones Under $300,000 Alzheimer’s Drug Discovery Foundation Award |
|
November 12, 2009
ST. LOUIS, MO – C2N Diagnostics reported today that it has successfully accomplished each of the milestones defined under its partnership with the Alzheimer’s Drug Discovery Foundation (ADDF) and ADDF’s affiliate, the Institute for the Study of Aging. Under the terms of the collaborative financing, ADDF awarded $300,000 to C2N for the purpose of readying the company to perform an industry-grade SILK-Aß™ assay. |
|
Read more...
|
|
|
C2N Diagnostics Launches Alzheimer’s Research Tool |
|
June 02, 2008, Business Wire
Research and Biomarker Platform Creates Potential to Accelerate Drug Development and Enable Earlier Detection of Alzheimer’s Disease and Other Debilitating Neurodegenerative Disorders. |
|
Read more...
|
|
|
Press Releases